Viewing Study NCT06389305


Ignite Creation Date: 2025-12-25 @ 3:26 AM
Ignite Modification Date: 2025-12-26 @ 2:06 AM
Study NCT ID: NCT06389305
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-04-30
First Post: 2024-04-24
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: CIK Cell Therapy for Relapsed or Refractory Acute B-Lymphoblastic Leukemia: Prognostic Impact on Patients With Early CAR-T Cell Dysfunction
Sponsor: Beijing GoBroad Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module